In this episode of Med Tech Talks, Robert Klupacs CEO of the Bionics Institute, chats with Sarah Meibusch, a partner at one of Australia’s largest venture capital firms, One Ventures, about the current life science venture capital climate and how industry stakeholders can best present their organisations to venture capitalists.

Sarah Meibusch specialises in sourcing life science companies and, using her global entrepreneurial and executional experience, plays a key role in shaping their future.

In this episode you will hear about:

Sarah's journey to becoming a venture capitalist
How industry stakeholders can best prepare themselves to be successful with venture capitalists
Sarah's thoughts on the current VC climate in Australia

More information:

Take a look at One Ventures' website

Learn more about Sarah Meibusch here

Updated version 05/08/22

Cómo superar la introversión, el sobreanálisis y crecer como COO: entrevista a Lucía Serrano [#488]